Foqus Technologies is pleased to receive AI technology commercialization support from the Ontario Bioscience Innovation Organization (OBIO®) through its Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence.
The LSCTC Centre supports the commercialization and adoption of innovative health technologies that drive intellectual property creation and strengthen Canada’s life sciences ecosystem. This funding will mainly support Foqus to explore and validate new concepts for the next generation of our machine learning algorithm — a key component of our Magnetic Resonance Imaging (MRI) software that powers advanced imaging performance
With OBIO’s support, Foqus will continue to advance its technology and expand the impact of its solutions in medical imaging.
